Target intelligence / Profile preview

Glutamate-rich protein (None)

Target: None
Molecular classification: Surface antigen

Overview

Glutamate-rich protein (GLURP) from *Plasmodium falciparum* is an immunogenic surface antigen involved in red blood cell invasion processes. It serves both as an important target for protective immunity/vaccine development and as a valuable molecular marker for epidemiological studies due to its high degree of polymorphism—especially within its repetitive domains.

Mechanism of action

ADCI (antibody-dependent cellular inhibition), opsonic phagocytosis

Biological functions

Erythrocyte bindingAdhesionImmune response

Disease associations

MalariaInfection

Beyond the preview

Go deeper on Glutamate-rich protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-rich protein (None).

Explore the full profile